Technology Commercialization Technology CommercializationTechnology CommercializationTechnology Commercializtion
Opportunities for Investors/Entrepreneurs For Industry
 
Message from the VP
T1000 Alumni Mentoring
Southwest Virginia Economic Development Program
Research at U.Va.
Office of the VP for Research & Graduate Studies
Policies & Forms
T100 Companies

ContraVac
DiaKine Therapeutics
Directed Vapor Technologies, Inc
Global Cell Solutions
MicroLab Diagnostics
PluroGen
PocketSonics
Tau Therapeutics
Virginia Diodes

Current Companies >>

Graduate Companies >>

Contact Us
P.O. Box 400301
Charlottesville, VA
22904-4301
434-924-7566
Office Staff >>
T100 banner


News Archive

CONTRAVAC RECEIVES FDA APPROVAL (03.03.08)

LAB AUTOMATION AWARD FOR T100 TECHNOLOGY (02.07.08)

HEALING ORTHOPAEDIC TECHNOLOGIES FOUNDER RECOGNIZED FOR ACL BREAKTHROUGHS (01.02.08)

PLUROGEN THERAPEUTICS PARTNERS WITH WELCARE INDUSTRIES (12.27.07)

NIH TO SPONSOR STUDY OF DIAKINE DRUG (10.09.07)

T100 COMPANIES IDENTIFIED AS GROWTH COMPANIES (09.25.07)

POCKETSONICS GRADUATES WITH CLEAR VISION FOR THE FUTURE (07.02.07)

DIAKINE THERAPEUTICS HONORED WITH BREAKTHROUGH AWARD (06.12.07)

GLOBAL CELL SOLUTIONS (GCS) ANNOUNCES PARTNERSHIP (05.18.07)

PLUROGEN RAISES $1.7M SEED, RAISING $7M SERIES A (04.13.07)

MICROLAB DIAGNOSTICS RECOGNIZED AS "BEST IN LIFE SCIENCES" (03.26.07)

TAU THERAPEUTICS NAMED ONE OF THE TOP 15 "BEST AND BRIGHTEST BIOTECHNOLOGY COMPANIES" IN THE SE (03.02.07)

SUPER SALVE: U.VA. COMPANY USES UNIQUE CREAM FOR BURNS (03.30.07)

TAU THERAPEUTICS CLOSES $500K ANGEL FUNDING (02.08.07)

 
 
spacer
spacer
 

Maintained by: Office of the Vice President for Research and Graduate Studies
Last Modified: 06-Aug-2008 08:19:40 EDT
© Copyright 2008 by the Rector and Visitors of the University of Virginia

Text-only Version
spacer